Tvardi Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Tweardy Samuel David | — | Other | 315,658 | — | — | — | Jul 7, 2025 |
| HALL WALLACE L JR | — | Award / Grant | 202,044 | — | — | 202,044 | Apr 15, 2025 |
| Wirk Shaheen | — | Award / Grant | 176,030 | — | — | 176,030 | Apr 15, 2025 |
| HALL WALLACE L JR | — | Other | 44,712 | — | — | 44,712 | Apr 15, 2025 |
| Wirk Shaheen | — | Other | 176,030 | — | — | 176,030 | Apr 15, 2025 |
| Posner Christopher | PRESIDENT AND CEO | Sale | 583 | $4.75 | $2,769 | 13,109 | Feb 28, 2025 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | 163 | $4.76 | $776 | 7,190 | Feb 28, 2025 |
| Posner Christopher | PRESIDENT AND CEO | Sale | 372 | $4.72 | $1,756 | 13,692 | Feb 4, 2025 |
| Posner Christopher | PRESIDENT AND CEO | Sale | 3,668 | $0.29 | $1,064 | 168,768 | Nov 4, 2024 |
| Posner Christopher | PRESIDENT AND CEO | Sale | 4,149 | $0.35 | $1,452 | 172,436 | Aug 1, 2024 |
| Boudreau Helen M | — | Award / Grant | 150,647 | — | — | 150,647 | Jun 4, 2024 |
| von Moltke Lisa | — | Award / Grant | 150,647 | — | — | 183,009 | Jun 4, 2024 |
| Ives Jeffrey L. | — | Award / Grant | 150,647 | — | — | 198,485 | Jun 4, 2024 |
| Shiff Susan Ph.D. | — | Award / Grant | 150,647 | — | — | 202,085 | Jun 4, 2024 |
| VOGELBAUM MARTIN | — | Award / Grant | 301,295 | — | — | 411,007 | Jun 4, 2024 |
| Posner Christopher | PRESIDENT AND CEO | Sale | 3,936 | $0.75 | $2,952 | 176,585 | May 2, 2024 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | Sale | 2,753 | $0.83 | $2,285 | 53,365 | Apr 5, 2024 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | 2,753 | $0.83 | $2,285 | 88,247 | Apr 5, 2024 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | 3,293 | $0.89 | $2,931 | 91,000 | Feb 29, 2024 |
| Posner Christopher | PRESIDENT AND CEO | Sale | 5,834 | $0.89 | $5,192 | 180,521 | Feb 29, 2024 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | Sale | 3,293 | $0.89 | $2,931 | 56,118 | Feb 29, 2024 |
| Posner Christopher | PRESIDENT AND CEO | Sale | 35,575 | $0.53 | $18,855 | 186,355 | Feb 8, 2024 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Award / Grant | 13,500 | — | — | 102,063 | Feb 1, 2024 |
| Maynard Ryan D | CHIEF FINANCIAL OFFICER | Award / Grant | 13,500 | — | — | 13,500 | Feb 1, 2024 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | Award / Grant | 13,500 | — | — | 67,181 | Feb 1, 2024 |
| Menzaghi Frederique Ph.D. | CHIEF SCIENTIFIC OFF,SVP-R&D | Award / Grant | 13,500 | — | — | 167,247 | Feb 1, 2024 |
| Posner Christopher | PRESIDENT AND CEO | Sale | 4,981 | $0.55 | $2,740 | 221,930 | Feb 1, 2024 |
| Posner Christopher | President and CEO | Sale | 3,796 | $1.22 | $4,631 | 164,411 | Nov 2, 2023 |
| Posner Christopher | President and CEO | Sale | 4,307 | $3.07 | $13,222 | 168,207 | Aug 3, 2023 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Sale | 2,483 | $3.51 | $8,715 | 88,563 | Jun 23, 2023 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Sale | 2,993 | $3.51 | $10,505 | 153,747 | Jun 23, 2023 |
| Goncalves Joana | Chief Medical Officer | Sale | 2,723 | $3.51 | $9,558 | 53,681 | Jun 23, 2023 |
| von Moltke Lisa | — | Award / Grant | 32,362 | — | — | 32,362 | Jun 1, 2023 |
| Shiff Susan Ph.D. | — | Award / Grant | 32,362 | — | — | 51,438 | Jun 1, 2023 |
| Ives Jeffrey L. | — | Award / Grant | 32,362 | — | — | 47,838 | Jun 1, 2023 |
| BAINS HARRISON M JR | — | Award / Grant | 32,362 | — | — | 57,438 | Jun 1, 2023 |
| VOGELBAUM MARTIN | — | Award / Grant | 64,724 | — | — | 109,712 | Jun 1, 2023 |
| Posner Christopher | President and CEO | Sale | 3,869 | $4.40 | $17,024 | 172,514 | May 5, 2023 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Sale | 2,481 | $4.91 | $12,182 | 91,046 | Apr 4, 2023 |
| Goncalves Joana | Chief Medical Officer | Sale | 2,481 | $4.91 | $12,182 | 56,404 | Apr 4, 2023 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Sale | 2,733 | $4.91 | $13,419 | 156,740 | Apr 4, 2023 |
| Posner Christopher | President and CEO | Sale | 5,987 | $9.71 | $58,134 | 176,383 | Mar 3, 2023 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | Sale | 6,802 | $9.71 | $66,047 | 159,473 | Mar 3, 2023 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | Sale | 6,256 | $9.71 | $60,746 | 93,527 | Mar 3, 2023 |
| Goncalves Joana | Chief Medical Officer | Sale | 6,221 | $9.71 | $60,406 | 58,885 | Mar 3, 2023 |
| Goncalves Joana | Chief Medical Officer | Sale | 2,265 | $10.20 | $23,103 | 65,106 | Feb 16, 2023 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | 7,770 | $0.53 | $4,118 | 94,293 | Feb 8, 2023 |
| Maynard Ryan D | CHIEF FINANCIAL OFFICER | Sale | 5,488 | $0.53 | $2,909 | 8,012 | Feb 8, 2023 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | Sale | 7,770 | $0.53 | $4,118 | 59,411 | Feb 8, 2023 |
| Posner Christopher | President and CEO | Sale | 4,191 | $11.80 | $49,454 | 182,370 | Feb 2, 2023 |